Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 917 of 6351
-
Pregnant women with hepatitis c get new hope from 12-Week drug trial
Disease control OngoingThis is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trimester in approximately 100 pregnant people. Maternal participants will take one …
Phase 4 • Sponsor: Catherine Anne Chappell • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a quick brain zap ease suicidal thoughts in depressed teens?
Symptom relief CompletedThe purpose of this study is to gather information regarding the use of a new type of transcranial magnetic stimulation (TMS) called theta burst stimulation (TBS) for suicidal ideation in adolescents with Major Depressive Disorder (MDD). The investigators hope to learn if this TM…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Immunotherapy drug shows promise for Tough-to-Treat colorectal cancer in china
Disease control OngoingIn this study, Chinese participants with MSI-H or dMMR advanced colorectal cancer will be assigned to receive either pembrolizumab or the Investigator's choice of 1 of 6 standard of care (SOC) chemotherapy regimens for treatment. There is no hypothesis testing for this study.
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New program aims to keep opioid overdose survivors on track to recovery
Disease control CompletedThis study targets individuals in Chicago who have received naloxone administered by first responders within the past week to reverse an overdose, but who have not entered into MAT. Study participants will be recruited through partnerships with the Chicago Fire Department (CFD) a…
Sponsor: Chestnut Health Systems • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Promising combo aims to boost remission in rare blood cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of venetoclax combined with azacitidine regimen for newly diagnosed T-ALL patients.
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can stem cell exosomes fade melasma patches?
Disease control CompletedMelasma is a refractory skin disease due to its complex pathogenesis and difficult treatment. Studies have found that human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) could serve as a novel cell-free therapeutic strategy in regenerative and aesthetic medi…
Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowA Phase I/II Dose Escalation, Safety and Efficacy Study of HBI 0201-ESO TCRT (anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes) Given by Infusion to Patients with NY-ESO-1 -Expressing Metastatic Cancers
Phase 1/2 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Texts vs. manuals: new trial aims to help rural cancer survivors kick the habit
Disease control Recruiting nowThis phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a VR headset turn a painful IV into a game?
Symptom relief CompletedThis randomized controlled trial was conducted to evaluate the effects of virtual reality and tablet-based audiovisual distraction on pain, anxiety, and fear in children undergoing intravenous cannulation in a pediatric emergency department. Children aged 7 to 12 years were rando…
Sponsor: Aydin Adnan Menderes University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could a single implant replace the morning-after pill?
Disease control Recruiting nowThe investigators propose a single site, single arm, open label mechanism of action pharmacodynamic pilot study of etonogestrel implant insertion prior to an luteinizing hormone (LH) surge. The investigators will evaluate ovulation rates via serum levels of reproductive hormones …
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Ocean disc melodies may soothe preemie breathing
Symptom relief Recruiting nowInfants born prematurely at will be asked to participate in this randomized controlled trial at a corrected gestational age of 24-37 weeks. Infants will be randomly selected to each of the two groups: intervention and control. Infants in the treatment group will receive six inter…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail aims to shrink head and neck tumors before treatment
Disease control Recruiting nowThe goal of this clinical trial is to test in describe participant population. The main questions it aims to answer are: 1. evaluate the efficacy and safety of tislelizumab combined with APF sequential surgery or radical concurrent chemoradiotherapy in the treatment of locally a…
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 26, 2026 14:12 UTC
-
New drug shows promise for rare liver disease in Late-Stage trial
Disease control CompletedSaroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)
Phase 2/3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
PET-Guided surgery could extend life for aggressive brain cancer patients
Disease control Recruiting nowBackground: Glioblastoma (GBM) is the most common primary brain tumor in adults, with a poor prognosis despite maximal treatment. Current evidence suggests that supramaximal resection, including non-enhancing FLAIR-hyperintense regions, improves survival. However, the extent of F…
Sponsor: Universita degli Studi di Genova • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New radiation implant shows promise for skin cancer
Disease control Recruiting nowA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Antibiotic-Infused bone graft could slash infection risk in hip replacements
Disease control Recruiting nowTotal hip replacement is the most successful treatment modern healthcare can offer patients to regain quality of life. Periprosthetic joint infection (PJI) is the most common and devastating complication after total hip replacement (THR). Between 0.5 to 2% of primary THR (first t…
Phase 2 • Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Immunotherapy shows promise against Hard-to-Treat colorectal cancer
Disease control CompletedIn this phase II study patients with stage II-III MSI/dMMR colorectal adenocarcinoma with no signs of distant metastases will be treated with immunotherapy (prolgolimab). The duration of treatment is 6 months (12 cycles)
Phase 2 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a Chest-Injected drug drain Cancer's fluid trap?
Disease control CompletedThis is an open-label, non-randomized, multicenter, translational Phase 1/2 dose-escalation and expansion study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of RSO-021 after intrapleural (IP) administratio…
Phase 1/2 • Sponsor: RS Oncology LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a new pill tame blood sugar in type 2 diabetes?
Disease control CompletedThe goal of this clinical trial is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with diet and exercise alone.
Phase 2 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope against deadly fungus: phase 3 trial launched
Disease control OngoingThe purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
Phase 3 • Sponsor: F2G Biotech GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC